Ultrafast MRI-Based Radiomics Model Shines in Breast Cancer Classification
Recent research published in La Radiologia Medica has unveiled a groundbreaking MRI-based radiomics model that performs on par with standard MRI scans in classifying breast cancers. This novel approach, immune to the variability of radiologist experience, holds significant promise for improving the accuracy and efficiency of breast cancer diagnosis.
The Study and Its Findings
A team of researchers led by Dr. Bo Kyoung Seo from Korea University in Ansan City, South Korea, conducted the study. They compared an ultrafast MRI radiomics model to standard MRI in classifying breast cancer subtypes and hormone receptor status among radiologists with varying levels of experience.
“Our study underscores the potential clinical utility of ultrafast MRI radiomics in breast cancer classification, irrespective of readers’ experience levels,” the team wrote.
Advantages of Ultrafast MRI
Ultrafast MRI offers several advantages over traditional MRI methodologies. It provides faster scan times, enhances temporal resolution, and offers improved lesion visibility compared to standard MRI. By capturing cancer enhancement before background enhancement, ultrafast MRI can make lesions more prominent. Additionally, it yields valuable data on time to enhancement (TTE), maximum slope, and wash-in slope, contributing to a more comprehensive evaluation.
Methodology and Results
The prospective study involved 225 women with 233 breast cancers before treatment between 2021 and 2022. Two readers—a breast radiologist with 24 years of experience (Reader 1) and a radiology resident with two years of experience (Reader 2)—performed tumor segmentation on MRI images. The researchers extracted radiomic features from both ultrafast and standard MRI images and employed logistic regression algorithms for prediction modeling.
Key findings include:
- The ultrafast MRI model performed better than the standard MRI model in predicting HER2 status.
- Both models showed similar accuracy in predicting hormone receptor status.
- Ultrafast MRI demonstrated superior classification of luminal subtype for both readers.
- Reader 1 accurately classified triple-negative subtypes using ultrafast MRI.
- Ultrafast MRI excelled in classification of HER2-overexpressed subtype for Reader 2.
Implications for Clinicians and Patients
The study highlights the potential of ultrafast MRI radiomics as a noninvasive tool for classifying breast cancers. Its ability to perform independently of radiologist experience suggests improved consistency in diagnosing breast cancer across different clinicians. Faster scan times and enhanced lesion visibility could also lead to quicker and more accurate diagnoses.
Ultrafast and standard MRI in a 30-year-old woman with triple-negative invasive ductal carcinoma. (A) Ultrafast MRI taken 16.8 seconds after contrast agent injection. (B) Standard MRI taken 58.8 seconds after contrast agent injection. Both images show an oval-shaped, irregular marginated, rim-enhancing mass in the left outer breast.
Springer Nature (open access)
Performance Metrics
| Performance of MRI radiomics models, readers in predicting HER2 status | |
|---|---|
| Method | Area under the curve (AUC) |
| Ultrafast MRI model (Reader 1) | 0.87 |
| Ultrafast MRI model (Reader 2) | 0.88 |
| Standard MRI model (Reader 1) | 0.77 |
| Standard MRI model (Reader 2) | 0.77 |
The table highlights the superior performance of the ultrafast MRI model in predicting HER2 status for both readers, compared to the standard MRI model.
The Future of Breast Cancer Diagnosis
The study authors emphasized the potential of ultrafast MRI radiomics to revolutionize breast cancer classification. They concluded that this approach addresses critical challenges associated with traditional MRI scans, including prolonged scan times and the subjective biases of individual radiologists.
“Our study demonstrates the promise of radiomics approaches with ultrafast MRI that have advantages in terms of scan time and lesion conspicuity, which are problems with standard MRI,” they noted.
Accessing the Full Study
For those interested in delving deeper into the research, the full study is available here.
Conclusion
The development of the ultrafast MRI-based radiomics model represents a significant step forward in breast cancer diagnosis. Its ability to achieve consistent and accurate results, regardless of the radiologist’s experience, suggests improved outcomes and potential cost savings for patients. As this technology matures, it could become a powerful tool in the hands of radiologists worldwide.
We encourage you to share your thoughts on this groundbreaking research. Join the conversation below!
Subscribe to Archynetys for more cutting-edge medical advancements and informative articles.
Share this article on social media to stay updated on the latest healthcare innovations:
